Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2024-08-07 AGM Information
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled 'Proceedings of the 5th Annual General Meeting' and details the events of the AGM held on August 7, 2024. It includes information about the meeting's attendees, the agenda items discussed (such as adoption of financial statements, dividend declaration, director appointments), shareholder questions, and voting procedures. The document is a summary of the AGM proceedings rather than the full Annual Report or financial statements themselves. It also references the Notice of AGM and Annual Report having been circulated earlier, indicating this document is a meeting summary. Therefore, this document fits the category of AGM Information (AGM-R). The document length (6791 characters) supports it being a detailed summary rather than a brief announcement or a full financial report.
2024-08-07 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of the company's audited financial results for the quarter ended June 30, 2024. It references compliance with SEBI Listing Regulations and states that the financial results have been published in newspapers. The document length is only 1700 characters, which is quite short and primarily serves as a notification of the publication of the financial results rather than containing the financial results themselves. According to the 'MENU VS MEAL' rule, such a short document that announces the publication of a report is classified as a Report Publication Announcement (RPA), not as the financial report itself (like an Interim/Quarterly Report). Therefore, the correct classification is RPA with high confidence.
2024-08-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the recording of an earnings conference call for the quarter ended June 30, 2024. It references Regulation 30 of SEBI (LODR) Regulations 2015, which pertains to disclosure requirements. The document states that the audio recording of the earnings call has been uploaded on the company's website and provides a link to access it. The document itself does not contain the transcript or detailed financial data, but is an announcement about the availability of the recording. The document length is short (1269 characters), and it serves as a notification rather than the actual earnings call transcript or financial report. Therefore, it should be classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the earnings call recording, not the transcript or financial results themselves.
2024-08-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 100% confidence The document is titled as a "Q1 FY25 Results Presentation" and is addressed to stock exchanges referencing Regulation 30 of SEBI (LODR) Regulations 2015, which governs disclosure of material events. The content includes detailed company overview, business highlights, financial snapshot including standalone revenue and EBITDA margins for Q1 FY25, strategic and financial overview, key milestones, board of directors, geographical presence, and manufacturing presence. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The presence of detailed financial data and strategic information aimed at investors confirms this is an investor presentation. It is not an earnings release (which would be a brief summary), nor an annual or quarterly report (which would contain full financial statements), nor a regulatory filing or announcement. Therefore, the correct classification is Investor Presentation (IP).
2024-08-05 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a communication from the company to stock exchanges (BSE and NSE) reporting the outcome of a Board Meeting held on August 5, 2024. It specifically mentions the approval of the Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2024, and the Auditor's Report on these financial results. The document includes detailed financial data for the quarter ended June 30, 2024, such as revenue, expenses, profit before tax, tax expenses, profit for the period, and earnings per share. The presence of detailed financial statements and analysis for a quarter indicates this is a quarterly financial report. The document is not merely an announcement that a report is available, but contains substantive financial data and results. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2024-08-05 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a communication from the company to stock exchanges (BSE and NSE) reporting the outcome of a Board Meeting held on August 5, 2024. It specifically mentions the approval of the Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2024, and the Auditor's Report on these financial results. The document includes detailed financial data such as revenue, expenses, profit before tax, tax expenses, and earnings per share for the quarter ended June 30, 2024. This indicates it is a comprehensive financial report for a quarter, containing actual financial statements and analysis. The reference to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, which govern disclosure of quarterly financial results, further supports this classification. The document is not merely an announcement of a report or a certification but contains substantive financial data for a quarter. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2024-08-05 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.